Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM P/E Multiple | 27.0x - 29.8x | 28.4x |
Selected Fwd P/E Multiple | 18.3x - 20.3x | 19.3x |
Fair Value | ﷼125 - ﷼138.16 | ﷼131.58 |
Upside | 0.8% - 11.4% | 6.1% |
Benchmarks | - | Full Ticker |
Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
Middle East Healthcare Company | 400,900.0% | SASE:4009 |
National Medical Care Company | 400,500.0% | SASE:4005 |
Dallah Healthcare Company | 400,400.0% | SASE:4004 |
- | - | - |
Select Price / LTM EPS Ratio | ||||||||
Benchmark Companies | ||||||||
4002 | 4007 | 4013 | 4009 | 4005 | 4004 | |||
SASE:4002 | SASE:4007 | SASE:4013 | SASE:4009 | SASE:4005 | SASE:4004 | |||
Historical Net Income Growth | ||||||||
5Y CAGR | 8.9% | 29.5% | 21.6% | 23.6% | 30.1% | 26.2% | ||
3Y CAGR | 3.8% | 50.8% | 18.9% | 154.0% | 29.8% | 22.1% | ||
Latest Twelve Months | 1.3% | 21.9% | 10.1% | 3545.6% | 13.6% | 31.9% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 26.5% | 20.5% | 20.0% | 3.9% | 18.0% | 12.9% | ||
Prior Fiscal Year | 24.3% | 25.8% | 21.5% | 0.6% | 22.3% | 12.2% | ||
Latest Fiscal Year | 22.4% | 29.4% | 20.7% | 9.8% | 23.0% | 14.7% | ||
Latest Twelve Months | 23.0% | 29.6% | 19.6% | 13.6% | 21.9% | 15.6% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | 15.6x | 15.2x | 34.8x | 11.7x | 20.5x | 21.2x | ||
Price / LTM Sales | 5.1x | 5.2x | 7.8x | 1.7x | 5.3x | 3.9x | ||
LTM P/E Ratio | 22.4x | 17.4x | 40.0x | 12.7x | 24.2x | 24.7x | ||
Low | Mid | High | ||||||
Benchmark LTM P/E Ratio | 12.7x | 22.4x | 40.0x | |||||
Historical LTM P/E Ratio | 27.5x | 33.5x | 51.7x | |||||
Selected P/E Multiple | 27.0x | 28.4x | 29.8x | |||||
(x) LTM Net Income | 507 | 507 | 507 | |||||
(=) Equity Value | 13,703 | 14,424 | 15,145 | |||||
(/) Shares Outstanding | 101.2 | 101.2 | 101.2 | |||||
Implied Value Range | 135.41 | 142.54 | 149.66 | |||||
FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 135.41 | 142.54 | 149.66 | 124.00 | ||||
Upside / (Downside) | 9.2% | 14.9% | 20.7% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | 4002 | 4007 | 4013 | 4009 | 4005 | 4004 | |
Value of Common Equity | 15,020 | 6,072 | 92,820 | 5,062 | 7,302 | 12,548 | |
(/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 92.0 | 44.7 | 101.2 | |
Implied Stock Price | 75.10 | 37.95 | 265.20 | 55.00 | 163.40 | 124.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 75.10 | 37.95 | 265.20 | 55.00 | 163.40 | 124.00 | |
Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |